Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Investment Securities: 2014-2025

Historic Gains from Investment Securities for Ocugen (OCGN) over the last 9 years, with Sep 2025 value amounting to -$37,000.

  • Ocugen's Gains from Investment Securities was N/A to -$37,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $103,000 for FY2024, which is 81.99% down from last year.
  • Ocugen's Gains from Investment Securities amounted to -$37,000 in Q3 2025, which was down 104.00% from $925,000 recorded in Q2 2025.
  • Ocugen's 5-year Gains from Investment Securities high stood at $951,000 for Q4 2023, and its period low was -$352,000 during Q1 2023.
  • Over the past 3 years, Ocugen's median Gains from Investment Securities value was $60,000 (recorded in 2023), while the average stood at $221,222.
  • As far as peak fluctuations go, Ocugen's Gains from Investment Securities plummeted by 119.67% in 2021, and later surged by 47,650.00% in 2023.
  • Over the past 5 years, Ocugen's Gains from Investment Securities (Quarterly) stood at -$36,000 in 2021, then skyrocketed by 94.44% to -$2,000 in 2022, then spiked by 47,650.00% to $951,000 in 2023, then soared by 228.74% to $112,000 in 2024, then surged by 725.89% to -$37,000 in 2025.
  • Its last three reported values are -$37,000 in Q3 2025, $925,000 for Q2 2025, and $428,000 during Q1 2025.